20 June 2013
Keywords: Allergan, First-quarter 2012 financial results
Article | 03 May 2012
USA-based Allergan (NYSE: AGN) reported financial results for the first quarter of 2012, with diluted earnings rocketing 45% to $230.3 million, or $0.74 per ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.